Les aspects actuels de l’usage de l’ecstasy/MDMA en France
| Autor: | Reynald Le Boisselier, Michel Spadari, Danièle Debruyne, Marylène Guerlais, Anne Batisse, Marion Lepelley, Alexandra Boucher, Céline Eiden, Sylvie Deheul, Anne Roussin, Amélie Daveluy, Elisabeth Frauger, Valérie Gibaja |
|---|---|
| Přispěvatelé: | Institut de Neurosciences des Systèmes (INS), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM) |
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
biology business.industry [SCCO.NEUR]Cognitive science/Neuroscience 010401 analytical chemistry Ecstasy Poison control Human factors and ergonomics MDMA biology.organism_classification 030226 pharmacology & pharmacy 01 natural sciences Suicide prevention 0104 chemical sciences 03 medical and health sciences 0302 clinical medicine Pill Injury prevention Medicine Pharmacology (medical) Cannabis business Psychiatry ComputingMilieux_MISCELLANEOUS medicine.drug |
| Zdroj: | Thérapie Thérapie, EDP Sciences-Depuis 2016, la revue Thérapie n’est plus publiée par EDP Sciences.> Therapies (Elsevier), 2016, 71 (6), pp.553-562. ⟨10.1016/j.therap.2016.05.005⟩ |
| ISSN: | 0040-5957 1958-5578 |
| DOI: | 10.1016/j.therap.2016.05.005 |
| Popis: | Methylenedioxymethamphetamine (MDMA), the active compound of ecstasy, has been used for several years, especially by young adults to benefit of psychostimulant properties. By raising the level of neuromodulators in the synapsis, MDMA can cause psychiatric and physical injuries. After reduced supplies in 2009 (number of ecstasy seizures equal to 10 percent of those recorded in 2002), judicial authorities now observed an increased availability (a half more part of seizures in 2012 than 2010). From its "Spontaneous Notifications" data base and "deaths in connection with the abuse of medicine and substances (DRAMES)", "observation of illegal drugs and misuse of psychotropic medications" (OPPIDUM), and "observation of drug dependencies in ambulatory medicine" (OPEMA) national inquiries, the French Addictovigilance network (CEIP-A) highlighted the increasing consumption of MDMA. The way of use appeared quite unchanged: users were mainly young men between 25 and 30 years; they favored an occasional use but mainly combined other products such as alcohol, cannabis and other stimulants. Severity of the clinical cases, based on hospital care and forensic data, could be consistent with the higher amounts of MDMA measured in pills. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|